Gainers
TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
ClearOne, Inc. (NASDAQ: CLRO) climbed 66.1% to $2.06 after the company announced a special one-time cash dividend of $1.00 per share of common stock, payable May 31 to shareholders of record on May 22, 2023.
Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 52.8% to $5.26 after the company announced completion of PF614-MPAR-101, a clinical study examining its first pain medication with overdose protection, PF614-MPAR.
Mobiquity Technologies, Inc. (NASDAQ: MOBQ) climbed 48.5% to $0.2302 after gaining around 7% on Monday.
Novavax, Inc. (NASDAQ: NVAX) shares climbed 46.4% to $10.91 after the company reported mixed Q1 financial results and issued FY23 revenue guidance above estimates.
Neuronetics, Inc. (NASDAQ: STIM) gained 37.3% to $3.02 after the company reported better-than-expected Q1 sales results, issued Q2 guidance and raised FY23 total worldwide revenue guidance.
Shengfeng Development Limited (NASDAQ: SFWL) rose 26.7% to $5.62.
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) climbed 25.6% to $8.51 following upbeat Q1 results.
VirnetX Holding Corporation (NYSE: VHC) surged 25.5% to $0.44 after the company announced a partnership with Samsung.
Tivic Health Systems, Inc. (NASDAQ: TIVC) gained 25.4% to $0.1630. Tivic Health, on Monday, launched a B2B portal.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares rose 22.1% to $10.15 after reporting a profit for the first quarter.
Rover Group, Inc. (NASDAQ: ROVR) gained 18.8% to $4.80 following strong quarterly results.
Palantir Technologies Inc. (NYSE: PLTR) surged 17.8% to $9.12 after the company reported strong Q1 results and said it expects to remain profitable each quarter through the end of the year.
Aris Water Solutions, Inc. (NYSE: ARIS) gained 17.5% to $8.47 following better-than-expected quarterly results.
Vivid Seats Inc. (NASDAQ: SEAT) rose 17.1% to $9.24 after the company reported better-than-expected Q1 sales results and raised FY23 revenue guidance above estimates.
Maris-Tech Ltd. (NASDAQ: MTEK) gained 17% to $0.9805 after the company announced it entered into an agreement with Art of Logic Australia for $7.5 million of a new product based on the company's Uranus-AI product.
ERYTECH Pharma S.A. (NASDAQ: ERYP) rose 17% to $1.03 after the company provided a business and financial update for Q1.
NeoGenomics, Inc. (NASDAQ: NEO) ...
Benzinga